ArticleCancers2026

Risk of Liver and Non-Liver Malignancy in HCV-Infected Patients with Cirrhosis After Direct-Acting Antiviral Treatment.

Dorota Zarębska-Michaluk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.